Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
05/06/201814:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
05/06/201812:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2018 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
01/06/201812:00GlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the First Quarter Ended 30 April 2018NASDAQ:SMMTSummit Therapeutics Inc
30/05/201811:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMMTSummit Therapeutics Inc
15/05/201821:49Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:SMMTSummit Therapeutics Inc
15/05/201821:44Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/05/201818:59Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
03/05/201821:41Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
24/04/201822:28Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
23/04/201812:00GlobeNewswire Inc.Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Present...NASDAQ:SMMTSummit Therapeutics Inc
23/04/201811:45GlobeNewswire Inc.Award of Share Options and Restricted Stock UnitsNASDAQ:SMMTSummit Therapeutics Inc
20/04/201812:00GlobeNewswire Inc.Summit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 American Academy of Neurology Annual MeetingNASDAQ:SMMTSummit Therapeutics Inc
19/04/201812:00GlobeNewswire Inc.Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical TrialNASDAQ:SMMTSummit Therapeutics Inc
13/04/201814:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SMMTSummit Therapeutics Inc
11/04/201821:48Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
11/04/201812:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018 and Operational Pr...NASDAQ:SMMTSummit Therapeutics Inc
09/04/201815:01GlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018NASDAQ:SMMTSummit Therapeutics Inc
05/04/201812:00GlobeNewswire Inc.Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
28/03/201812:00GlobeNewswire Inc.Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual MeetingNASDAQ:SMMTSummit Therapeutics Inc
27/03/201813:42Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
27/03/201812:00GlobeNewswire Inc.Summit Therapeutics Announces Placement of £15.0 Million of Ordinary SharesNASDAQ:SMMTSummit Therapeutics Inc
14/03/201811:00GlobeNewswire Inc.Summit Highlights Scientific Rigour of its PhaseOut DMD Clinical Trial at MDA Clinical ConferenceNASDAQ:SMMTSummit Therapeutics Inc
13/03/201811:00GlobeNewswire Inc.Summit’s Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea...NASDAQ:SMMTSummit Therapeutics Inc
07/03/201812:00GlobeNewswire Inc.Summit Expands Enrolment in PhaseOut DMD Phase 2 Clinical Trial to Include Planned Additional GroupNASDAQ:SMMTSummit Therapeutics Inc
26/02/201821:46Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
26/02/201812:00GlobeNewswire Inc.Summit Announces New Analysis Showing Ezutromid Significantly Reduced Muscle Inflammation in Phase 2 Clinical Trial in DMDNASDAQ:SMMTSummit Therapeutics Inc
23/02/201812:00GlobeNewswire Inc.Summit Therapeutics to Participate in 2018 BTIG Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
14/02/201820:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SMMTSummit Therapeutics Inc
09/02/201812:00GlobeNewswire Inc.Summit Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:SMMTSummit Therapeutics Inc
30/01/201817:41Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT